✦ LIBER ✦

Ablative Local Therapy Extends the Clinical Benefit of Crizotinib in Alk-positive Lung Cancer

✍ Scribed by Gan, G.N.; Camidge, D.R.; Weickhardt, A.J.; Doebele, R.C.; Dzingle, W.; Scheier, B.; Kavanagh, B.D.

Book ID: 123105675
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 78 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.281

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe Acute Interstitial Lung Disease A

Severe Acute Interstitial Lung Disease After Crizotinib Therapy in a Patient With EML4-ALK-Positive Non-Small-Cell Lung Cancer

✍ Tamiya, A.; Okamoto, I.; Miyazaki, M.; Shimizu, S.; Kitaichi, M.; Nakagawa, K. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 819 KB

Correlations between the percentage of t

Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase (ALK) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization–positive nonsmall cell lung cancer

✍ D. Ross Camidge; Mariana Theodoro; DeLee A. Maxson; Margaret Skokan; Tara O'Brie 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

PCN73 Economic Analysis of the Use of Cr

PCN73 Economic Analysis of the Use of Crizotinib, a Tyrosine Kinase ALK Inhibitor, in the Treatment of ALK Positive Non-Small Cell Lung Cancer in the Mexican Setting

✍ J.G. Gay-Molina; R. Sánchez-Kobashi; E. Muciño-Ortega; C.I. Gutiérrez-Colín; R.M 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Changing clinical practice: Extending th

Changing clinical practice: Extending the benefits of adjuvant endocrine therapy in breast cancer

✍ Paul E. Goss 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Activity and safety of crizotinib in pat

Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study

✍ D Ross Camidge; Yung-Jue Bang; Eunice L Kwak; A John Iafrate; Marileila Varella- 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 310 KB

Extending the Clinical Benefit of Endocr

Extending the Clinical Benefit of Endocrine Therapy for Women With Hormone Receptor–Positive Metastatic Breast Cancer: Differentiating Mechanisms of Action

✍ Glück, Stefan 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 670 KB